Why the study?
Does PTCA improve stenosis and clinical outcomes in patients with left main stem stenosis following protective CABG?
Does PTCA improve stenosis and clinical outcomes in patients with left main stem stenosis following protective CABG?
PTCA of the left main stem following protective CABG is a relatively safe and effective procedure, though it is associated with a marked restenosis rate.
Answers are grounded in this paper and cite their sources.
PTCA may be feasible post-protective CABG; hypothesis-generating case-report data leave efficacy, restenosis, and practice change unresolved.
Percutaneous transluminal coronary angioplasty (PTCA) was performed in 14 patients with significant left main stem stenosis following protective coronary artery bypass grafting (CABG). The procedure was successful in 13/14 patients (93%), achieving a decrease in mean diameter stenosis from 74% +/- 7% to 31% +/- 12% (P less than 0.01). Accordingly, the absolute stenosis diameter increased from 0.9 mm +/- 0.3 mm to 2.4 mm +/- 0.5 mm (P less than 0.01). Dissection of the left main stem artery and a transient significant fall of blood pressure each occurred in one patient. No other serious complications were noted. Eight of 13 patients (62%) with successful PTCA underwent control angiography. Restenosis had occurred in 3 of 8 patients (38%) with total occlusion of the left main stem in 1 patient. All bypass grafts were found to be patent at follow-up. Clinical evaluation in all 14 patients revealed no serious events (death, myocardial infarction, repeat revascularization procedure) during a mean follow-up period of 27 months (range 6-39 months). PTCA of the left main stem following CABG can be considered a relatively safe and effective procedure with a marked restenosis-rate but beyond that, an uncomplicated long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Rupprecht et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: